ReviewJournal of cardiovascular translational research2026
Factors Modulating Mitochondrial Function after Arterial Injury: Past-to-Present Evidence for the Devising of Future Preventive and Therapeutic Strategies.
Review in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Vascular trauma can lead to adverse outcomes if remodeling is uncontrolled. Intimal hyperplasia (IH) is a key process that contributes to luminal narrowing during remodeling and is strongly influenced by mitochondria. Enhanced mitochondrial ATP production and increased production of reactive oxygen species (ROS), along with reduced apoptosis in vascular smooth muscle cells (VSMCs), have been shown to promote IH. In addition, endothelial injury could initiate mitochondrial dysfunction and apoptosis which compromise endothelial integrity and function, leading to the exposure of VSMCs to various circulating factors, thus triggering IH. Therefore, reduction of mitochondrial ATP production, reduction of ROS, and induction of apoptosis in VSMC after vascular injury may present promising strategies in preventing IH. Conversely, promoting re-endothelialization prevents exposure of VSMCs to blood circulation. This review provides comprehensive insights from in vitro and in vivo reports of potential therapeutic strategies attempt to alleviate IH and achieve optimal outcomes.
Indexed as
Identifiers
42426536What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.